Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:1303-1307
Published online before print February 17, 2003, doi: 10.1161/01.CIR.0000054612.26458.B2
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/9/1303    most recent
01.CIR.0000054612.26458.B2v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Solomon, D. H.
Right arrow Articles by Curhan, G. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Solomon, D. H.
Right arrow Articles by Curhan, G. C.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Attack
*Joint Disorders
*Rheumatoid Arthritis
*Stroke
Related Collections
Right arrow Acute myocardial infarction
Right arrow Acute Cerebral Infarction
Right arrow Epidemiology

(Circulation. 2003;107:1303.)
© 2003 American Heart Association, Inc.


Clinical Investigation and Reports

Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis

Daniel H. Solomon, MD, MPH; Elizabeth W. Karlson, MD; Eric B. Rimm, ScD; Carolyn C. Cannuscio, ScD; Lisa A. Mandl, MD, MPH; JoAnn E. Manson, MD, DrPH; Meir J. Stampfer, MD, DrPH; Gary C. Curhan, MD, ScD

From the Division of Pharmacoepidemiology and Pharmacoeconomics (D.H.S.), Division of Rheumatology, Immunology, and Allergy (D.H.S., E.W.K., L.A.M.), and Division of Preventive Medicine, Channing Laboratory (J.E.M., M.J.S., G.C.C.); Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass; Department of Epidemiology (E.B.R., M.J.S., G.C.C.), Harvard School of Public Health, Boston, Mass; and Merck Research Laboratories (C.C.C.), West Point, Pa.

Correspondence to Daniel H. Solomon, MD, MPH, Divisions of Pharmacoepidemiology and Rheumatology, Immunology, and Allergy, Brigham and Women’s Hospital, 221 Longwood Ave, Suite 341, Boston MA 02115. E-mail dhsolomon{at}partners.org

Background— Rheumatoid arthritis may be associated with an increased risk of cardiovascular disease. We compared the incidence rates of myocardial infarction and stroke in subjects with and without rheumatoid arthritis.

Methods and Results— A prospective cohort study was conducted among the 114 342 women participating in the Nurses’ Health Study who were free of cardiovascular disease and rheumatoid arthritis at baseline in 1976. All self-reported cases of rheumatoid arthritis were confirmed by medical record review. Fatal and nonfatal myocardial infarctions and strokes were similarly confirmed. Multivariate pooled logistic regression was used to adjust for potential cardiovascular risk factors. Five hundred twenty-seven incident cases of rheumatoid arthritis and 3622 myocardial infarctions and strokes were confirmed during 2.4 million person-years of follow-up. The adjusted relative risk of myocardial infarction in women with rheumatoid arthritis compared with those without was 2.0 (95% confidence interval [CI], 1.23 to 3.29). For stroke, the adjusted relative risk was 1.48 (95% CI, 0.70 to 3.12). Women who had rheumatoid arthritis for at least 10 years had a risk for myocardial infarction of 3.10 (95% CI, 1.64 to 5.87).

Conclusion— In this large prospective cohort of women, participants with rheumatoid arthritis had a significantly increased risk of myocardial infarction but not stroke compared with those without rheumatoid arthritis. If these data are confirmed, aggressive coronary heart disease prevention strategies should be tested for persons with rheumatoid arthritis.


Key Words: cardiovascular diseases • myocardial infarction • stroke • epidemiology




This article has been cited by other articles:


Home page
The Journal of RheumatologyHome page
C. GARCIA-GOMEZ, J. M. NOLLA, J. VALVERDE, J. A. GOMEZ-GERIQUE, M. J. CASTRO, and X. PINTO
Conventional Lipid Profile and Lipoprotein(a) Concentrations in Treated Patients with Rheumatoid Arthritis
J Rheumatol, July 1, 2009; 36(7): 1365 - 1370.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. Turiel, F. Atzeni, L. Tomasoni, S. de Portu, L. Delfino, B. D. Bodini, M. Longhi, S. Sitia, M. Bianchi, P. Ferrario, et al.
Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients
Rheumatology, July 1, 2009; 48(7): 834 - 839.
[Abstract] [Full Text] [PDF]


Home page
BMJ Case ReportsHome page
A. G. Semb, S. Provan, T. Kvien, and T. Pedersen
Effect of high-intensity statin treatment in rheumatoid arthritis: a case with possible coronary atheroma regression and progression of rheumatoid valve degeneration
BMJ Case Reports, June 21, 2009; 2009(jun21_1): bcr0820080717 - bcr0820080717.
[Abstract] [Full Text]


Home page
Ann Rheum DisHome page
E Choy and N Sattar
Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions
Ann Rheum Dis, April 1, 2009; 68(4): 460 - 469.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
N J Goodson, A M Brookhart, D P M Symmons, A J Silman, and D H Solomon
Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients
Ann Rheum Dis, March 1, 2009; 68(3): 367 - 372.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
F. Montecucco, F. Burger, G. Pelli, N. K. Poku, C. Berlier, S. Steffens, and F. Mach
Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes
Rheumatology, March 1, 2009; 48(3): 233 - 242.
[Abstract] [Full Text] [PDF]


Home page
The Journal of RheumatologyHome page
S. R.E. BRADY, B. de COURTEN, C. M. REID, F. M. CICUTTINI, M. P.J. de COURTEN, and D. LIEW
The Role of Traditional Cardiovascular Risk Factors Among Patients with Rheumatoid Arthritis
J Rheumatol, January 1, 2009; 36(1): 34 - 40.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
S. Darabian, A. Reza Amirzadegan, H. Sadeghian, S. Sadeghian, A. Abbasi, and M. Raeesi
Ostial Lesions of Left Main and Right Coronary Arteries: Demographic and Angiographic Features
Angiology, January 1, 2009; 59(6): 682 - 687.
[Abstract] [PDF]


Home page
CirculationHome page
M. Y. Chan, F. Andreotti, and R. C. Becker
Hypercoagulable States in Cardiovascular Disease
Circulation, November 25, 2008; 118(22): 2286 - 2297.
[Full Text] [PDF]


Home page
CirculationHome page
A. J. Flammer, I. Sudano, F. Hermann, S. Gay, A. Forster, M. Neidhart, P. Kunzler, F. Enseleit, D. Periat, M. Hermann, et al.
Angiotensin-Converting Enzyme Inhibition Improves Vascular Function in Rheumatoid Arthritis
Circulation, April 29, 2008; 117(17): 2262 - 2269.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
V. F. Panoulas, K. M. J. Douglas, A. Stavropoulos-Kalinoglou, G. S. Metsios, P. Nightingale, M. D. Kita, M. S. Elisaf, and G. D. Kitas
Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis
Rheumatology, January 1, 2008; 47(1): 72 - 75.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
A Gonzalez, H M. Kremers, C S Crowson, K V Ballman, V L Roger, S J Jacobsen, W M O'Fallon, and S E Gabriel
Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
Ann Rheum Dis, January 1, 2008; 67(1): 64 - 69.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. P. Forman
Arthritis Is Associated With Cardiovascular Disease in the Users of Analgesics and Nonsteroidal Anti-inflammatory Drugs Reply
Arch Intern Med, November 26, 2007; 167(21): 2372 - 2372.
[Full Text] [PDF]


Home page
CirculationHome page
M. J. Roman and J. E. Salmon
Cardiovascular Manifestations of Rheumatologic Diseases
Circulation, November 13, 2007; 116(20): 2346 - 2355.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
V. F. Panoulas, H. J. Milionis, K. M. J. Douglas, P. Nightingale, M. D. Kita, R. Klocke, M. S. Elisaf, and G. D. Kitas
Association of serum uric acid with cardiovascular disease in rheumatoid arthritis
Rheumatology, September 1, 2007; 46(9): 1466 - 1470.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
V. F. Panoulas, K. M. J. Douglas, H. J. Milionis, A. Stavropoulos-Kalinglou, P. Nightingale, M. D. Kita, A. L. Tselios, G. S. Metsios, M. S. Elisaf, and G. D. Kitas
Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis
Rheumatology, September 1, 2007; 46(9): 1477 - 1482.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. C. Knockaert
Cardiac involvement in systemic inflammatory diseases
Eur. Heart J., August 1, 2007; 28(15): 1797 - 1804.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. E. Munroe, J. L. Arbiser, and G. A. Bishop
Honokiol, a Natural Plant Product, Inhibits Inflammatory Signals and Alleviates Inflammatory Arthritis
J. Immunol., July 15, 2007; 179(2): 753 - 763.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
J. C Waksman, A. Brody, and S. D Phillips
Nonselective Nonsteroidal Antiinflammatory Drugs and Cardiovascular Risk: Are They Safe?
Ann. Pharmacother., July 1, 2007; 41(7): 1163 - 1173.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
F. Del Porto, B. Lagana, S. Lai, I. Nofroni, F. Tinti, M. Vitale, E. Podesta, A. P. Mitterhofer, and R. D'Amelio
Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis
Rheumatology, July 1, 2007; 46(7): 1111 - 1115.
[Abstract] [Full Text] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
G. L. Montagna, F. Cacciapuoti, R. Buono, D. Manzella, G. A. Mennillo, A. Arciello, G. Valentini, and G. Paolisso
Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis
Diabetes and Vascular Disease Research, June 1, 2007; 4(2): 130 - 135.
[Abstract] [PDF]


Home page
J. Epidemiol. Community HealthHome page
J. Ahnquist, P. Fredlund, and S. P Wamala
Is cumulative exposure to economic hardships more hazardous to women's health than men's? A 16-year follow-up study of the Swedish Survey of Living Conditions
J Epidemiol Community Health, April 1, 2007; 61(4): 331 - 336.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
D H Solomon, N J Goodson, J N Katz, M E Weinblatt, J Avorn, S Setoguchi, C Canning, and S Schneeweiss
Patterns of cardiovascular risk in rheumatoid arthritis
Ann Rheum Dis, December 1, 2006; 65(12): 1608 - 1612.
[Abstract] [Full Text] [PDF]


Home page
DTBHome page
Combination therapy for early rheumatoid arthritis
DTB, November 1, 2006; 44(11): 81 - 85.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. A. Quyyumi
Inflamed Joints and Stiff Arteries: Is Rheumatoid Arthritis a Cardiovascular Risk Factor?
Circulation, September 12, 2006; 114(11): 1137 - 1139.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
D. Aeberli, M. Leech, and E. F. Morand
Macrophage migration inhibitory factor and glucocorticoid sensitivity
Rheumatology, August 1, 2006; 45(8): 937 - 943.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
C. Hur, A. T Chan, A. C Tramontano, and G S. Gazelle
Coxibs Versus Combination NSAID and PPI Therapy for Chronic Pain: An Exploration of the Risks, Benefits, and Costs
Ann. Pharmacother., June 1, 2006; 40(6): 1052 - 1063.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
L Bjornadal, L Brandt, L Klareskog, and J Askling
Impact of parental history on patients' cardiovascular mortality in rheumatoid arthritis
Ann Rheum Dis, June 1, 2006; 65(6): 741 - 745.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
V P van Halm, M C Slot, M T Nurmohamed, J W Cohen Tervaert, B A C Dijkmans, and A E Voskuyl
Antibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis
Ann Rheum Dis, May 1, 2006; 65(5): 590 - 594.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
N P Riksen, P Barrera, P H H van den Broek, P L C M van Riel, P Smits, and G A Rongen
Methotrexate modulates the kinetics of adenosine in humans in vivo
Ann Rheum Dis, April 1, 2006; 65(4): 465 - 470.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. S. Bhatia, M. D. Sosin, J. V. Patel, K. A. Grindulis, F. H. Khattak, E. A. Hughes, G. Y.H. Lip, and R. C. Davis
Left Ventricular Systolic Dysfunction in Rheumatoid Disease: An Unrecognized Burden?
J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1169 - 1174.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
M. J. Roman, E. Moeller, A. Davis, S. A. Paget, M. K. Crow, M. D. Lockshin, L. Sammaritano, R. B. Devereux, J. E. Schwartz, D. M. Levine, et al.
Preclinical carotid atherosclerosis in patients with rheumatoid arthritis.
Ann Intern Med, February 21, 2006; 144(4): 249 - 256.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
F. C. Hall and N. Dalbeth
Disease modification and cardiovascular risk reduction: two sides of the same coin?
Rheumatology, December 1, 2005; 44(12): 1473 - 1482.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Mineo, A. K. Gormley, I. S. Yuhanna, S. Osborne-Lawrence, L. L. Gibson, L. Hahner, R. V. Shohet, S. Black, J. E. Salmon, D. Samols, et al.
Fc{gamma}RIIB Mediates C-Reactive Protein Inhibition of Endothelial NO Synthase
Circ. Res., November 25, 2005; 97(11): 1124 - 1131.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Shoenfeld, R. Gerli, A. Doria, E. Matsuura, M. M. Cerinic, N. Ronda, L. J. Jara, M. Abu-Shakra, P. L. Meroni, and Y. Sherer
Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases
Circulation, November 22, 2005; 112(21): 3337 - 3347.
[Full Text] [PDF]


Home page
Eur Heart JHome page
W. S. Speidl, M. Exner, J. Amighi, S. P. Kastl, G. Zorn, G. Maurer, O. Wagner, K. Huber, E. Minar, J. Wojta, et al.
Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis
Eur. Heart J., November 1, 2005; 26(21): 2294 - 2299.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
N Goodson, J Marks, M Lunt, and D Symmons
Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s
Ann Rheum Dis, November 1, 2005; 64(11): 1595 - 1601.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
R Gerli and N J Goodson
Cardiovascular involvement in rheumatoid arthritis
Lupus, September 1, 2005; 14(9): 679 - 682.
[Abstract] [PDF]


Home page
LupusHome page
P Sarzi-Puttini, F Atzeni, A Doria, L Iaccarino, and M Turiel
Tumor necrosis factor-a, biologic agents and cardiovascular risk
Lupus, September 1, 2005; 14(9): 780 - 784.
[Abstract] [PDF]


Home page
HypertensionHome page
P. S. Wang, J. Avorn, M. A. Brookhart, H. Mogun, S. Schneeweiss, M. A. Fischer, and R. J. Glynn
Effects of Noncardiovascular Comorbidities on Antihypertensive Use in Elderly Hypertensives
Hypertension, August 1, 2005; 46(2): 273 - 279.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
C. Turesson, L. Jacobsson, A. Ryden Ahlgren, G. Sturfelt, P. Wollmer, and T. Lanne
Increased stiffness of the abdominal aorta in women with rheumatoid arthritis
Rheumatology, July 1, 2005; 44(7): 896 - 901.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. B. Kritchevsky, M. Cesari, and M. Pahor
Inflammatory markers and cardiovascular health in older adults
Cardiovasc Res, May 1, 2005; 66(2): 265 - 275.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
I del Rincon, R W Haas, S Pogosian, and A Escalante
Lower limb arterial incompressibility and obstruction in rheumatoid arthritis
Ann Rheum Dis, March 1, 2005; 64(3): 425 - 432.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Hermann, A. Forster, R. Chenevard, F. Enseleit, D. Hurlimann, R. Corti, L. E. Spieker, D. Frey, M. Hermann, W. Riesen, et al.
Simvastatin improves endothelial function in patients with rheumatoid arthritis
J. Am. Coll. Cardiol., February 1, 2005; 45(3): 461 - 464.
[Full Text] [PDF]


Home page
Ann Rheum DisHome page
M Hoekstra, C J Haagsma, C J A Doelman, and M A F J van de Laar
Intermittent rises in plasma homocysteine in patients with rheumatoid arthritis treated with higher dose methotrexate
Ann Rheum Dis, January 1, 2005; 64(1): 141 - 143.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
N. Dalbeth, J. Edwards, S. Fairchild, M. Callan, and F. C. Hall
The non-thiol angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis
Rheumatology, January 1, 2005; 44(1): 24 - 31.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
L. M. Fischer, R. G. Schlienger, C. M. Matter, H. Jick, and C. R. Meier
Discontinuation of Nonsteroidal Anti-inflammatory Drug Therapy and Risk of Acute Myocardial Infarction
Arch Intern Med, December 13, 2004; 164(22): 2472 - 2476.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
K L Hyrich, A J Silman, K D Watson, and D P M Symmons
Anti-tumour necrosis factor {alpha} therapy in rheumatoid arthritis: an update on safety
Ann Rheum Dis, December 1, 2004; 63(12): 1538 - 1543.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Krishnan, V. B. Lingala, and G. Singh
Declines in Mortality From Acute Myocardial Infarction in Successive Incidence and Birth Cohorts of Patients With Rheumatoid Arthritis
Circulation, September 28, 2004; 110(13): 1774 - 1779.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P Jepsen, S P Johnsen, M W Gillman, and H T Sorensen
Interpretation of observational studies
Heart, August 1, 2004; 90(8): 956 - 960.
[Full Text] [PDF]


Home page
Ann Rheum DisHome page
C Turesson, A Jarenros, and L Jacobsson
Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study
Ann Rheum Dis, August 1, 2004; 63(8): 952 - 955.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. A. Garcia Rodriguez, C. Varas-Lorenzo, A. Maguire, and A. Gonzalez-Perez
Nonsteroidal Antiinflammatory Drugs and the Risk of Myocardial Infarction in the General Population
Circulation, June 22, 2004; 109(24): 3000 - 3006.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Gerli, G. Schillaci, A. Giordano, E. B. Bocci, O. Bistoni, G. Vaudo, S. Marchesi, M. Pirro, F. Ragni, Y. Shoenfeld, et al.
CD4+CD28- T Lymphocytes Contribute to Early Atherosclerotic Damage in Rheumatoid Arthritis Patients
Circulation, June 8, 2004; 109(22): 2744 - 2748.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
G F Ferraccioli and E Gremese
Autoantibodies and thrombophilia in RA: TNF{alpha} and TNF{alpha} blockers
Ann Rheum Dis, June 1, 2004; 63(6): 613 - 615.
[Full Text]


Home page
CirculationHome page
D. H. Solomon, S. Schneeweiss, R. J. Glynn, Y. Kiyota, R. Levin, H. Mogun, and J. Avorn
Relationship Between Selective Cyclooxygenase-2 Inhibitors and Acute Myocardial Infarction in Older Adults
Circulation, May 4, 2004; 109(17): 2068 - 2073.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
T. D. WARNER and J. A. MITCHELL
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
FASEB J, May 1, 2004; 18(7): 790 - 804.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A.D. Booth, D.R.W. Jayne, R.K. Kharbanda, C.M. McEniery, I.S. Mackenzie, J. Brown, and I.B. Wilkinson
Infliximab Improves Endothelial Dysfunction in Systemic Vasculitis: A Model of Vascular Inflammation
Circulation, April 13, 2004; 109(14): 1718 - 1723.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J.-E. Gottenberg, C. Sordet, J. Sibilia, T. Kurth, R. J. Glynn, A. M. Walker, K. A. Chan, J. E. Buring, C. H. Hennekens, and J. M. Gaziano
Inhibition of Clinical Benefits of Aspirin on First Myocardial Infarction by Nonsteroidal Antiinflammatory Drugs * Response
Circulation, March 9, 2004; 109 (9): e157 - e157.
[Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
W. Dai and R. A. Kloner
Relationship Between Cyclooxygenase-2 Inhibition and Thrombogenesis
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1): 51 - 59.
[Abstract] [PDF]


Home page
Evid. Based Nurs.Home page
OTHER ARTICLES NOTED (25 Apr 2003 to 18 Jul 2003)
Evid. Based Nurs., October 1, 2003; 6(4): e1 - 12.
[Full Text]


Home page
Evid. Based Med.Home page
ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB
Evid. Based Med., September 1, 2003; 8(5): 131 - 131.
[Full Text] [PDF]


Home page
JWatch Women's HealthHome page
Women with Rheumatoid Arthritis Are at Increased Risk for MI
Journal Watch Women's Health, May 20, 2003; 2003(520): 9 - 9.
[Full Text]


Home page
Rheumatology (Oxford)Home page
Robin Goodfellow (42-5)
Rheumatology, May 1, 2003; 42(5): 710 - 710.
[Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
Rheumatoid Arthritis -- CVD Risk Factor?
Journal Watch Cardiology, April 18, 2003; 2003(418): 2 - 2.
[Full Text]